As shown in Figures 1C–1G, Ang II infusion resulted in hypertension and cardiac dysfunction, with a significant increase in systolic blood pressure and a reduction in LV ejection fraction (LVEF) and LV fractional shortening (LVFS) as well as an increase in LV mass when compared with saline-treated mice. The gene discussed is AGT; the disease is hypertensive disorder.